Peter Frederick on Nostr: Published 11 July 2023 The paper is new and examines everything we know about long ...
Published 11 July 2023
The paper is new and examines everything we know about long covid.
"Here, we focus on current thinking about the pathophysiology of long COVID and the evidence for potential underpinning mechanisms. It will be evident from this that, although great progress has been made, we are far from a coherent schema linking SARS-CoV-2 infection to the diverse array of persistent symptoms that have been described. Hypothesized mechanisms include end-organ damage, a persistent SARS-CoV-2 reservoir, an abnormal immune response to acute COVID-19, an effect of reactivation of other viruses such as Epstein–Barr virus (EBV), altered systemic immunity, auto-immunity (including effects on the autonomic nervous system), coagulopathy and microbiome dysbiosis. Different disease descriptors may clearly impact those tests chosen for analysis and, in turn, whether particular participants are selected for a given clinical trial."
npub1j92gv04tmkesqun87xgr4hnvzcwx0f49yyzl37pa7rew8uslugjs9j6nfj (npub1j92…6nfj)
#CovidIsNotOver
#LongCovid
#CovidIsAirborne
To keep yourself and family and community safe and to slow down the rise of new variants:
Wear a respirator, keep vaccinations up to date, clean air, isolate when infectious.
https://www.nature.com/articles/s41577-023-00904-7
The paper is new and examines everything we know about long covid.
"Here, we focus on current thinking about the pathophysiology of long COVID and the evidence for potential underpinning mechanisms. It will be evident from this that, although great progress has been made, we are far from a coherent schema linking SARS-CoV-2 infection to the diverse array of persistent symptoms that have been described. Hypothesized mechanisms include end-organ damage, a persistent SARS-CoV-2 reservoir, an abnormal immune response to acute COVID-19, an effect of reactivation of other viruses such as Epstein–Barr virus (EBV), altered systemic immunity, auto-immunity (including effects on the autonomic nervous system), coagulopathy and microbiome dysbiosis. Different disease descriptors may clearly impact those tests chosen for analysis and, in turn, whether particular participants are selected for a given clinical trial."
npub1j92gv04tmkesqun87xgr4hnvzcwx0f49yyzl37pa7rew8uslugjs9j6nfj (npub1j92…6nfj)
#CovidIsNotOver
#LongCovid
#CovidIsAirborne
To keep yourself and family and community safe and to slow down the rise of new variants:
Wear a respirator, keep vaccinations up to date, clean air, isolate when infectious.
https://www.nature.com/articles/s41577-023-00904-7